14-103126515-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006291.4(TNFAIP2):āc.58T>Cā(p.Tyr20His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000113 in 1,580,632 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006291.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNFAIP2 | NM_006291.4 | c.58T>C | p.Tyr20His | missense_variant | 2/12 | ENST00000560869.6 | NP_006282.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNFAIP2 | ENST00000560869.6 | c.58T>C | p.Tyr20His | missense_variant | 2/12 | 5 | NM_006291.4 | ENSP00000452634 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151528Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000197 AC: 4AN: 202936Hom.: 0 AF XY: 0.0000362 AC XY: 4AN XY: 110378
GnomAD4 exome AF: 0.000123 AC: 176AN: 1429104Hom.: 0 Cov.: 31 AF XY: 0.000124 AC XY: 88AN XY: 709162
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151528Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 73996
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2022 | The c.58T>C (p.Y20H) alteration is located in exon 1 (coding exon 1) of the TNFAIP2 gene. This alteration results from a T to C substitution at nucleotide position 58, causing the tyrosine (Y) at amino acid position 20 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at